Neuronetics (STIM) director granted 36,250 RSUs, holdings rise to 625,017 shares

Rhea-AI Filing Summary

Neuronetics, Inc. director Robert Cascella received a grant of 36,250 restricted stock units of common stock as equity compensation. The award has no cash exercise price and will vest on the earlier of May 28, 2027, or a Board-approved separation or change in control, subject to his continuous service. After this grant, Cascella holds 625,017 shares of Neuronetics common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CASCELLA ROBERT

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	36,250	$0.00	--

Holdings After Transaction: Common Stock — 625,017 shares (Direct, null)

Footnotes (1)

1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Key Figures

RSU grant size: 36,250 shares Transaction price per share: $0.00 per share Holdings after transaction: 625,017 shares +1 more

4 metrics

RSU grant size 36,250 shares Restricted stock unit award to director Robert Cascella

Transaction price per share $0.00 per share Equity compensation, not an open-market purchase

Holdings after transaction 625,017 shares Total direct ownership after RSU grant

RSU vesting date May 28, 2027 Vests earlier if Board-approved separation or change in control occurs

Key Terms

restricted stock unit, RSU, change in control, contingent right

4 terms

restricted stock unit financial

"Represents a restricted stock unit ("RSU") award that vests on the earlier of"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

RSU financial

"Represents a restricted stock unit ("RSU") award that vests on the earlier of"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

change in control financial

"separation of service from the Issuer or change in control of the Issuer"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

contingent right financial

"Each RSU represents a contingent right to receive one share"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CASCELLA ROBERT

(Last) (First) (Middle)

C/O NEURONETICS, INC.

3222 PHEONIXVILLE PIKE

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		A		36,250(1)	A	$0(2)	625,017	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date.

2. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	/s/ Francis Brown, as Attorney-in-Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Neuronetics (STIM) report for Robert Cascella?

Neuronetics reported that director Robert Cascella received a grant of 36,250 restricted stock units of common stock. This is an equity compensation award, not an open-market purchase or sale, and increases his directly held position in the company.

How many Neuronetics (STIM) shares does Robert Cascella hold after this Form 4?

Following the restricted stock unit grant, Robert Cascella holds 625,017 shares of Neuronetics common stock directly. This figure reflects his updated ownership position as reported in the Form 4 after the equity award was recorded.

When do Robert Cascella’s Neuronetics (STIM) RSUs vest?

The restricted stock unit award vests on the earlier of May 28, 2027, or a Board-approved separation from service or change in control of Neuronetics. Vesting is conditioned on Cascella’s continuous service through the applicable vesting date.

What does each RSU in Robert Cascella’s Neuronetics (STIM) grant represent?

Each restricted stock unit represents a contingent right to receive one share of Neuronetics common stock. The shares are delivered only upon vesting, subject to the service-based and event-based conditions outlined in the award’s terms.

Was cash paid for Robert Cascella’s Neuronetics (STIM) RSU grant?

No cash was paid for the RSU grant; the per-share transaction price is reported as $0.00. The award represents stock-based compensation granted by Neuronetics rather than a purchase transaction on the open market.